ASCL1 and cancer: For patient P22 with MANEC, almost all cancer cells highly expressed NAPSA, and some of them coexpressed ASCL1. Therefore, unlike ADC patients P5, P10, P11, and P13, patients P19 and P22 mainly had NET and ADC mixed-lineage cancer cells (Fig. 3a).